Showing results (471-480 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|May 14, 2019
Revised international surveillance case definition of transfusion-associated circulatory overload: a classification agreement validation studyJohanna C Wiersum-Osselton, Barbee Whitaker, Sharran Grey, et al.
The Lancet. Haematology|October 29, 2021
Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trialsAmir Enshaei, Ajay Vora, Christine J Harrison, et al.
The Lancet. Haematology|March 10, 2022
Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trialNicholas Crombie, Heidi A Doughty, Jonathan R B Bishop, et al.
The Lancet. Haematology|March 3, 2022
Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trialHanny Al-Samkari, Jaroslaw Kolb-Sielecki, Sufiia Z Safina, et al.
The Lancet. Haematology|March 3, 2022
Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trialSabina Kersting, Julie Dubois, Kazem Nasserinejad, et al.
The Lancet. Haematology|June 29, 2019
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trialBrenda M Sandmaier, Brian Kornblit, Barry E Storer, et al.
The Lancet. Haematology|March 29, 2023
Endemic or regionally limited parasitic and fungal infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) ReviewIbrahim N Muhsen, Sebastian Galeano, Dietger Niederwieser, et al.
The Lancet. Haematology|April 1, 2023
Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trialAlok Srivastava, Savita Rangarajan, Kaan Kavakli, et al.
The Lancet. Haematology|March 26, 2021
Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)Sarah Gillessen, Annette Plütschow, Michael Fuchs, et al.
The Lancet. Haematology|March 26, 2021
Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trialLu Sun, Juan Wang, Linlin Shao, et al.
Pageof 73